Color offers genetic testing and health screening services to individuals, healthcare providers, and employers, focusing on preventive healthcare. Their products include various genetic tests, such as COVID-19 testing, which can be purchased directly or ordered through healthcare professionals. Color differentiates itself by providing personalized health programs for employees and emphasizing the security and privacy of personal health information. The company's goal is to enhance health awareness and decision-making through accessible genetic insights.

Drew Houston

Padmasree Warrior

LeFrak

Aaron Levie

Raymond Tonsing

Max Levchin

Ruchi Sanghvi

Julia Hartz

Lee Linden

Mariam Naficy

Avichal Garg

Formation 8

#Angels

AME Cloud Ventures

Katie Stanton

Khosla Ventures

Ben Davenport

Laurene Powell Jobs

General Catalyst

General Catalyst Partners

Viking Global Investors

T. Rowe Price

Emerson Collective

Kindred Ventures

Healthcare

Color

The American Cancer Society (ACS) and Color Health today announced the launch of their new pilot program to provide free at-home colorectal cancer screening kits to individuals in rural areas and other underserved communities, where barriers to healthcare access often hinder timely screening and early detection.

Expanding Access in Cancer Care

- The American Cancer Society (ACS) and Color Health have joined forces to launch a new pilot program aimed at increasing access to colorectal cancer screening in underserved communities.

American Cancer Society, Color Health to Offer Free At-Home Colorectal Cancer Screening in Underserved Rural Communities

What You Should Know:– The American Cancer Society (ACS) and Color Health have joined forces to launch a new pilot program aimed at increasing access to colorectal cancer screening in underserved communities.– The program, recognized by the White House Office of Science and Technology Policy, seeks to address disparities in cancer outcomes and improve early detection rates.The Importance of Colorectal Cancer Early DetectionColorectal cancer is highly treatable when detected early. However, many Americans continue to be diagnosed at late stages, leading to poorer outcomes. The program seeks to close these access gaps by providing free at-home fecal immunochemical test (FIT) kits to eligible individuals.How the Program WorksDistribution: Participating Federally Qualified Health Centers (FQHCs) and community clinics in rural and non-urban areas will receive FIT kits to distribute to eligible patients at no cost.Participating Federally Qualified Health Centers (FQHCs) and community clinics in rural and non-urban areas will receive FIT kits to distribute to eligible patients at no cost. Patient Support: Color Health will provide comprehensive support throughout the screening process, including test activation, result delivery, and care coordination.Color Health will provide comprehensive support throughout the screening process, including test activation, result delivery, and care coordination. Results Sharing: Test results will be securely shared with healthcare providers, ensuring timely follow-up for patients with abnormal findings.Benefits for Clinics and PatientsFree Access: The program is entirely free for both clinics and patients, eliminating financial barriers to screening.The program is entirely free for both clinics and patients, eliminating financial barriers to screening. Enhanced Community Health: Participating clinics can improve access to cancer screening services for their patients, contributing to overall community health.Participating clinics can improve access to cancer screening services for their patients, contributing to overall community health

American Cancer Society, Color Health To Offer Free At-Home Colorectal Cancer Screening In Underserved Rural Communities

The most popular applications of artificial intelligence (AI) today typically center around automating routine tasks. But that’s not to say that the innovation doesn’t hold extraordinary potential beyond its mastery of the mundane. Within healthcare, AI’s ability to ingest vast amounts of data and analyze it instantaneously could help usher in a new era of medical innovation and patient care — particularly when applied to historically intractable problems and diseases, such as cancer

Exclusive: Color Ceo Says Ai-For-Oncology Copilots Detect And Treat Cancer Earlier

In fact, OpenAI is partnering with Color Health on an AI copilot to assist doctors in cancer screening and in creating treatment plans after a doctor has made a diagnosis.

AI-Driven Behavior Change Could Transform Health Care

Color Health has developed an AI assistant using OpenAI's GPT-4 model.

The Creative Power of 20 Questions

For instance, Microsoft-backed OpenAI has partnered with Color Health to develop AI-driven cancer care solutions.

This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan

最近、動画生成 AI モデルがニュースをにぎわせているが、AI の大規模言語モデル（LLM）側でも新しい取り組みがたくさん行われている。その一例として、OpenAI は17日、カリフォルニア州バーリンゲームにある創業11年のスタートアップ Color Health と提携し、がん専門医が最もリスクの高い患者に対してどのような検査を指示すべきかを理解するためのコパイロットアプリを発表した。このアプリは、OpenAI の最新のマルチモーダルモデル「GPT-4o」を使用して、個々の患者の医療データとその危険因子を、常に変化する医療ガイドラインのリストと比較し、その患者にパーソナライズされたがん検診計画を作成し、まだ必要かもしれない未解決の検査を医師に通知する。どの患者がどの検査をどのくらい早く受けるべきか？ GPT-4o と OpenAI のモデルは、高い精度を維持しながら、医師が以前よりも早くこれらの質問に答え、理想的にはがんや前がん状態を早期に発見し、より迅速な治療と患者の転帰の改善を可能にすることが期待されている。複数の医師、Color Health のコパイロットアプリの支援に名乗りを上げるOpenAI のコラボレーションに関する投稿の中で、Color Health のプライマリケア医師 Keegan Duchicela 氏は、高リスク患者のためのパーソナライズされたがん検診計画を開発することの複雑さを強調した。私は、高リスク患者のために個別化されたがん検診計画を策定することの複雑さを目の当たりにしてきました。ガイドラインは常に進化していますし、個々の危険因子がすぐに明らかになるとは限りません。Wall Street Journal が報じたこの提携に関する記事によると、このアプリの追跡調査により、医師は Color Health の GPT-4o を搭載したコパイロットアプリを使って5分で患者の記録を分析できることがわかったという。スタンフォード大学医学部教授の Allison Kurian 氏は、OpenAI のブログ投稿で次のように証言している。私の患者の多くは、適切な治療を提供するために必要なすべての検査と評価を完了するのに数週間を要し、その間に貴重な時間が失われ、臨床医にさらなる管理負担がかかります。がんは、心臓病に次いでアメリカで2番目に大きな死因であり、医療費の多くを占めているため、検診と治療を迅速化し改善するための努力は、間違いなく歓迎されるだろう。Color Health とは？2013年に Othman Laraki 氏、Elad Gil 氏、Nish Bhat 氏、Taylor Sittler 氏によって、がんリスクを評価する遺伝子検査サービス「23andMe」の競合のような存在として設立された Color Health は、それ以来、サンプル収集、臨床サポート、全50州の700万人の患者へのケアなど、がん患者の経験全般に焦点を当てている。同社は昨年、検診や予防から効果的な管理まで包括的ながんケアを提供するために ACS（American Cancer Society、アメリカがん協会）と提携し、2024年5月には ACS と共同で、低所得者や保険未加入者を対象に今月から無料で自宅での大腸がん検診を提供し、早期発見を強化してがん関連の医療費を削減する計画で、ホワイトハウスのイニシアチブ「Cancer Moonshot」の一部として言及された。また、患者が感染症や心臓代謝性疾患の治療を受けられるよう支援する。Color Health の CEO Othman Laraki 氏は、OpenAI の公式ブログに掲載された声明の中で次のように述べている。Color Health のビジョンは、がんに関する専門知識を、患者のヘルスケアに関する意思決定に最も大きな影響を与えることができる時点とタイミングで利用できるようにすることです。アクセス可能な専門知識のビジョンLaraki 氏は自身の X アカウントを通じて、医療へのタイムリーなアクセスの重要性について詳しく述べた。適切なタイミングでサービスや情報にアクセスできるようにすることは、私たちができる他のどんなことよりも優れていることが多いのです。Through our work with 7mm patients & @AmericanCancer, we've seen the impact of access firsthand. Simply put: Healthcare being available doesn’t make it accessible. Making services and information accessible at the right time often outweighs anything else we can do. — Othman Laraki (@othman) June 17, 2024Laraki 氏はさらに、ヘルスケアにおける生成 AI のチャンスについて次のように語った。私たちは、AI 革命が、重要な医療情報やサービスへのアクセスと即時性を向上させる最大の機会であることに賭けています。ヘルスケアの複雑さと幅広さを考えると、患者の旅の重要な瞬間に専門知識にアクセスすることが常に課題となっています。Our bet is that the GenAI revolution is the biggest opportunity to improve access and immediacy to critical health information & services. Given the complexity and breadth of healthcare, a constant challenge is access to expertise at critical moments in a patient’s journey. — Othman Laraki (@othman) June 17, 2024PoCColor Health と OpenAI のコラボレーションは、昨年の GPT-4o のリリースのかなり前から始まり、不整合なフォーマットの患者データの解釈、密集した医療ガイドラインの分析、患者データのプライバシーの保護に焦点を当てていた。OpenAI の指導のもと、Color Health は標準的な ChatGPT インターフェースを使用して臨床ワークフローのプロトタイプを作成し、カスタム GPT モデルを使用してサンプルケースを生成した。このアプローチにより、Color Health は役に立たなかったり実行不可能なアイデアにエンジニアリングリソースを投入する前に、PoC を開発することができた。Laraki 氏は、X に集中したアプローチを強調し、次のように述べている。生成 AI のような新しい技術では、海を沸騰させようとする罠に陥りがちです。私たちは、大風呂敷を広げるのではなく、専門家へのアクセスに制約される、いくつかの特定の、しかし非常にインパクトのあるユースケース／シナリオをサポートするために、臨床医の能力を深くスケーリングしました。With new tech like GenAI, it's tempting to fall into the trap of trying to boil the ocean

ヘルスケアスタートアップのColor Health、がん検診のコパイロットアプリでOpenaiと提携

Color Health will launch a copilot application based on OpenAI's latest GPT-4o technology designed to help identify missing cancer diagnostics and create tailored treatment plans, according to a story on OpenAI's website.

Color Health to launch a GPT-4o 'copilot'

Video AI generator models have been hogging the news cycle lately, but there are plenty of new initiatives happening on the large language model (LLM) side of AI, too.Case in point: yesterday, OpenAI announced it had partnered with Color Health, an 11-year-old Burlingame, California startup, to launch a copilot app for cancer specialists to help them understand what tests to order up for their most at-risk patients.The app uses OpenAI’s newest multimodal model GPT-4o to compare medical data of individual patients, and their risk factors, to the constantly changing list of healthcare guidelines — developing personalized cancer screening plans for said patients, and pinging doctors with what outstanding tests may still be needed.What tests should which patients get, and how soon? The hope and early indications are that GPT-4o and OpenAI’s models more generally can help doctors answer these questions faster than they could have before, while maintaining high accuracy, ideally catching cancer or pre-cancerous conditions earlier and enabling for faster treatment and improved patient outcomes.Doctors come forward in support of Color’s GPT-4o powered copilot appIn OpenAI’s post on the collaboration, Dr. Keegan Duchicela, a primary care physician at Color, highlighted the complexities of developing personalized cancer screening plans for high-risk patients. “I’ve witnessed the complexities of developing personalized cancer screening plans for my high-risk patients. The guidelines are constantly evolving, and individual risk factors aren’t always immediately clear.”A Wall Street Journal story on the partnership mentions that a trail of the app found that doctors were able to analyze patient records in 5 minutes using Color’s GPT-4o-powered copilot app — a process that can sometimes take hours to weeks otherwise.Dr. Allison Kurian, a professor at Stanford University School of Medicine, attested as much in OpenAI’s blog post, stating: “Many of my patients require weeks to complete all of the tests and evaluations necessary to provide appropriate treatment, during which precious time is lost and additional administrative burden is placed on clinicians.”Cancer is the second leading cause of death in the United States behind heart disease, and a major driver of healthcare costs, so any effort to expedite and improve screening and treatment will no doubt be welcome.What is Color Health?Founded in 2013 by Othman Laraki, Elad Gil, Nish Bhat and Taylor Sittler as a kind of 23andMe genetic testing competitor to evaluate cancer risks, Color Health has since focused on overall cancer patient experience including sample collection, clinical support, and care to 7 million patients in all 50 states.The company partnered with the American Cancer Society last year to provide comprehensive cancer care from screening and prevention to effective management and was mentioned as part of the White House’s “Cancer Moonshot” initiative in May 2024 for its plan, in conjunction with ACS, to offer free at-home colorectal cancer screenings for under- and uninsured individuals starting this month, enhancing early detection and reducing cancer-related healthcare costs.It also helps patients find care for infectious and cardiometabolic diseases.“Color’s vision is to make cancer expertise accessible at the point and time when it can have the greatest impact on a patient’s healthcare decisions,” said Othman Laraki, CEO of Color Health, in a statement posted on OpenAI’s official company blog.A vision for accessible expertiseThrough his X account, Laraki elaborated on the importance of timely access to healthcare, stating, “Healthcare being available doesn’t make it accessible. Making services and information accessible at the right time often outweighs anything else we can do.”Through our work with 7mm patients & @AmericanCancer, we've seen the impact of access firsthand.Simply put: Healthcare being available doesn’t make it accessible

Why Healthcare Startup Color Is Partnering With Openai On A Cancer Screening Copilot App

Provides genetic testing and health screenings

Color

Provides genetic testing and health screenings

Color

Provides genetic testing and health screenings

About

Simplify's Take

What believers are saying

What critics are saying

What makes Color unique

6 month growth

1 year growth

2 year growth

Benefits

Recently Posted Jobs

Color is Hiring for 0 Jobs on Simplify!